Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2005 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for NDA: 020569

« Back to Dashboard

Summary for NDA: 020569

Tradename:
VITRASERT
Applicant:
Bausch And Lomb
Ingredient:
ganciclovir
Patents:1
Therapeutic Class:Antivirals
Glossary

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:IMPLANT; IMPLANTATIONStrength4.5MG
Approval Date:Mar 4, 1996TE:RLD:Yes
Patent:5,378,475Patent Expiration:JAN 03,2012Product Flag?Substance Flag?Delist Request?
Patented Use:


Complete Access Available with Subscription
« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc